Ignite Creation Date:
2025-12-24 @ 7:14 PM
Ignite Modification Date:
2026-01-04 @ 6:06 PM
Study NCT ID:
NCT03896503
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-19
First Post:
2019-03-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell Cancers Outside of the Lungs
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-12-30
Start Date Type:
ACTUAL
Primary Completion Date:
2022-12-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-06-23
Completion Date Type:
ESTIMATED
First Submit Date:
2019-03-27
First Submit QC Date:
None
Study First Post Date:
2019-04-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-08-08
Results First Submit QC Date:
None
Results First Post Date:
2024-11-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-02
Last Update Post Date:
2025-09-19
Last Update Post Date Type:
ESTIMATED